Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
REDMOND, Wash., Nov 15, 2010 (BUSINESS WIRE) -- Physio-Control, Inc., a wholly-owned subsidiary of Medtronic, Inc., (NYSE: MDT), announced today it has received 510(k) clearance from the U.S. Food...
SAN ANTONIO & REDMOND, Wash., Nov 15, 2010 (BUSINESS WIRE) -- Innovative new mobile cardiac monitoring solutions are on the horizon. At the American Heart Association Scientific Sessions 2010,...
MINNEAPOLIS & CHICAGO, Nov 14, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the landmark RAFT (Resynchronization/Defibrillation for Ambulatory Heart Failure Trial)...
MINNEAPOLIS, Nov 12, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the second quarter of its fiscal year 2011 on Tuesday, November 23,...
MINNEAPOLIS, Nov 04, 2010 (BUSINESS WIRE) -- In support of Bladder Health Awareness Month and the struggles 33 million Americans face year-round with bladder control issues, Medtronic, Inc. (NYSE:...
MINNEAPOLIS, Nov 01, 2010 (BUSINESS WIRE) -- Advancing the minimally invasive treatment of aortic aneurysms, Medtronic, Inc. (NYSE: MDT), today announced approval by the U.S. Food and Drug...
MINNEAPOLIS, Nov 18, 2010 (BUSINESS WIRE) -- Medtronic Inc. (NYSE: MDT), the leader in spinal cord stimulation for more than 25 years, today announced U.S. Food and Drug Administration (FDA)...
MINNEAPOLIS, Oct 29, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) has classified the company's previous action related to the...
MINNEAPOLIS, Oct 21, 2010 (BUSINESS WIRE) -- Medtronic Inc. (NYSE:MDT) today announced Food and Drug Administration (FDA) clearance of the Kyphon Xpander II Inflatable Bone Tamp (IBT) for the...
MINNEAPOLIS, Oct 15, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) conditional approval for its Investigational Device Exemption (IDE)...